DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Telli ML, Metzger O, Timms K. et al.
Evaluation of homologous recombination deficiency (HRD) status with pathological response to carboplatin ± veliparib in BrighTNess, a randomized phase 3 study in early stage TNBC.
J Clin Oncol 2018;
36 (Suppl.) Abstr.. 519
We do not assume any responsibility for the contents of the web pages of other providers.